期刊文献+

血管内皮生长因子基质金属蛋白酶-2和-9在胸腔积液检测中的临床意义 被引量:3

下载PDF
导出
摘要 本文探讨胸腔枳掖中血管内皮生长因子(VEGF)、基质金属蛋白酶(MMP)-2及MMP-9的表达,明确其在良、恶性胸腔积液中的鉴别作用,以期为临床工作提供必要的理论支持。
作者 陈小兰
出处 《中国药物与临床》 CAS 2009年第8期714-715,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献5

二级参考文献20

  • 1余辉,吴一龙,戎铁华,李锦添,王思愚,区伟,林素暇,侯景辉.非小细胞肺癌组织中p53蛋白的表达对预后及术后化放疗疗效的影响[J].肿瘤研究与临床,2006,18(1):16-18. 被引量:12
  • 2Curran S, Murray GI. Matrix metalloproteinases in tumout invasion and metastasis[J]. J Pathol, 1999, 189:300
  • 3Yeo KT, Wang HH, Nagy JA, et al. Vascular permeability factor(vascular endothelial growth factor) in guinea pig and human tumor and infiammotory effusion [J]. Cancer Res,1993, 53: 2912
  • 4Yano S, Herbst RS, Shinohara H, Knighton B, et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation[J]. Clin Cancer Res.2000, 6(3): 957
  • 5Welty-Wolf KE, Carraway MS, Huang YT, Simonson SG,Kantrow SP, Kishimoto TK,Piantadosi CA. Antibody to intercellular adhesion molecule-1 (CD54) decreases survival and not lung injury in baboons with sepsis[J]. Am. J. Respir.Crit. Care Med, 2001, 163:665
  • 6Springer TA. Adhesion receptors of the immune system[J].Nature, 1990, 346:425
  • 7许良中.实用肿瘤病理方法学[M].上海:上海医科大学出版社,1996.
  • 8FONG K,SEKIDO Y,GAZDAR J D,et al.Lung cancer:Molecular biology of lung cancer clinical implications[ J ].Thorax,2003,58(10):892-900.
  • 9JOHNSON B E,FREIDLIN B,CONLEY B,et al.Phase Ⅲ trials in patients with advanced stage non-small cell lung cancer from 1973-1994[J].Proceedings ASCO,2000,19(2):488.
  • 10SEIJI Y,YASUHIKO N,HISATSUGN G,et al.Molecular mechanisms of angiogenesis in non-small cell lung cancer,and therapeutics targeting related molecules[ J ].Cancer Sci,2003,94 (6):479-485.

共引文献11

同被引文献37

  • 1李丹,曾波航,于宪.血清瘦素和TNF-α与恶性肿瘤恶液质的关系[J].实用肿瘤学杂志,2006,20(1):7-8. 被引量:8
  • 2孙瑜,王良兴,王惠军,李翊卫.VEGF、CD44_(V6)、MMP联合检测对良、恶性胸水的鉴别意义[J].温州医学院学报,2006,36(4):350-353. 被引量:6
  • 3刘娟,刘纯,彭林.多种肿瘤标志物联合检测在良恶性胸水中的诊断价值[J].医学临床研究,2007,24(3):469-471. 被引量:29
  • 4Wagner iC,Guirnaraes MJ,da Silva LK,et ai.Tumor necrosis fAcLor-alpha promote malignant pleural effusion[J]. Bras Pneumol, 2007,33(2): 185-191.
  • 5Buyukoglan H C-ulmez I,Kelestimur F,et al.Leptin levels in various manifestations of pulrnonary tuberculosis[J].Mediators lnflamm,2007,55(]6):648-659.
  • 6Charpin C,Dales JP,Garcia S,et al.Tumor neoangiogenesis by CDSi and CD105 expression evaluation in breast carcinoma tissue microarrays[J].Clin Cancer R, es, 2004, 10(17): 5815-5819.
  • 7BENNETT R,MASKELL N. Management of malignant pleural effusions[J]. Current Opinion in Pulmonary Medicine, 2005, 11(4):296-300.
  • 8Shi HZ, Liang QL, Jiang J, et al. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis [J]. Respirology, 2008, 13(4): 518-527.
  • 9Bezuglova TV, Poliakova GA, Kazantseva IA. Role of immunohistochemical study of extracellular matrix components in the estimation of the malignant potential of adrenal pheochromocytomas[J]. Arkh Patol, 2008,70(6) : 19-21.
  • 10杨春燕.血清及胸水中MMP-9和CDl47的检测对肺癌恶性胸腔积液的诊断价值[C].徐州医学院2011年硕士学位论文.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部